Hemodialysis and Peritoneal Dialysis Market Size, Share  & Industry Trends 2028 `

Posted by mahesh on October 13th, 2022

According to our new research study on "Hemodialysis and Peritoneal Dialysis Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Product, and End User," the market is expected to grow from US$ 84,610.62 million in 2021 to US$ 130,370.18 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2022 to 2028. The report highlights trends prevailing in the market and factors governing the growth of the hemodialysis and peritoneal dialysis market. Increasing incidence of chronic kidney diseases propel the market growth. However, risks and complications associated with dialysis limit the market growth.

Hemodialysis (HD) is the most common renal replacement therapy (RRT) modality practiced worldwide. For example, the number of HD stations in India was estimated to be 12,881 in 2018. The Union Government announced a National Dialysis Program in 2016 focusing on setting up eight-station dialysis facilities in 688 districts in India, offering HD to poor patients. Further, the Centers for Disease Control and Prevention (CDC) report states that ~ 36 million adults are suffering from chronic kidney diseases (CKD) in the US. Every 24 hours, 360 people begin dialysis treatment for kidney failure. Moreover, in the past few years, the requirement for dialysis has increased stupendously. Therefore, the increasing prevalence of End-Stage Renal Disease (ESRD)  drives the adoption of hemodialysis and peritoneal dialysis.

Request Sample PDF Brochure – https://www.theinsightpartners.com/sample/TIPHE100001128/

Increasing adoption of self-care dialysis and rising initiatives by competitive players for introducing advanced products and services propel the growth of the hemodialysis and peritoneal dialysis market. According to the report by the American Association of Kidney Patients (AAKP), self-care (home) dialysis therapies, such as peritoneal dialysis and home hemodialysis, are receiving significant attention for patients suffering from CKD across the world. Also, the adoption of hemodialysis and peritoneal dialysis as effective therapies and treatments for patients suffering from ESRD is increasing. Therefore, if self-care benefits are identified, it may prove as one of the remarkable therapy options for patients suffering from CKD that may include improved healthcare outcomes.

Rising number of strategies by leading players in the hemodialysis and peritoneal dialysis market drives the overall market growth. For instance, in December 2020, Medtronic announced the launch of the first and only pediatric and neonatal acute dialysis machine in the US. The newly launched product, namely "Carpediem" system, is designed for treating patients requiring renal replacement therapy weighing between 2.5 and 10 kilograms (5.5 to 22 pounds). The newly launched product has been successfully installed and is used in Cincinnati Children's Hospital Medical Center.

Based on type, the hemodialysis and peritoneal dialysis market is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis segment led the market in 2021 and is expected to retain its dominance during the forecast period. Hemodialysis, also known as "haemo," is a dialysis treatment recommended for kidney failure patients. According to the statistics revealed by the University of California San Francisco, nearly 750,000 patients in the US and an estimated two million patients globally suffer from kidney failure on an annual basis. Hemodialysis is a recommended procedure for patients suffering from kidney (or renal) failure and is performed among 90% of all dialysis patients worldwide. As per the University of California San Francisco report, 35% of hemodialysis patients remain alive for almost 5 years after treatment.

Furthermore, a report by the Department of Health & Human Services USA states that the U.S. Food and Drug Administration has approved devices for home hemodialysis and actively supports innovations in medical devices, intended for hemodialysis through its breakthrough programs and participation in "KidneyX," the Kidney Innovation Accelerator. The report further states that 87% of Americans suffering from kidney failure start their treatment with hemodialysis. The United States Renal Data System (US RDS) data revealed that about 63.1% of all prevalent End-Stage Renal Disease (ESRD) patients received hemodialysis therapy in 2016. These factors are significantly responsible for the segmental growth in the global hemodialysis and the peritoneal dialysis market, ultimately contributing to the overall market's development during the forecast period. Such aforementioned factors support the growth of the hemodialysis and peritoneal dialysis market for the hemodialysis segment.

The National Kidney Foundation report states that, there are two kinds of dialysis. In hemodialysis, blood is pumped out of patient's body to an artificial kidney machine, and return to the patient's body by tubes that connect to the machines. In peritoneal dialysis, the inside lining of patient's own belly acts as a natural filter. Major factors driving the market growth include the increasing prevalence of kidney diseases, and increasing prevalence of diabetes. Additionally, the market strategies by key players is likely to emerge as a significant future trend in the market during the forecast period. However, risks and complications with dialysis hamper the hemodialysis and peritoneal dialysis market growth.

The hemodialysis and peritoneal dialysis market are majorly comprised of top players involving Fresenius Medical Care AG & Co KGaA; DaVita Inc.; Baxter International Inc.; B. Braun Melsungen AG; Diaverum; Nipro Medical Corporation; Evoqua Water Technologies LLC. (Mar Cor Purification); Asahi Kasei Medical Co., Ltd.; Rockwell Medical, Inc.; Dialife SA; among others.

Access Full Report @ https://www.theinsightpartners.com/reports/hemodialysis-and-peritoneal-dialysis-market

The companies listed above are implementing various strategies such as product launches, acquisitions, mergers, and partnerships, which have resulted in the company's growth and, in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876